Hyperfine (HYPR) Projected to Announce Earnings on Monday

Key Points

• Hyperfine is expected to report Q3 2026 earnings after Monday’s market close, with analysts forecasting a loss of $0.08 per share and revenue of $5.84 million.
• In the prior quarter, Hyperfine reported a $0.09-per-share loss in line with estimates, while revenue of $3.90 million fell short of the $4.13 million consensus forecast.
• Shares recently traded near their 52-week low at $0.73, although analysts maintain a “Moderate Buy” consensus and an average price target of $2.02.

Hyperfine (NASDAQ:HYPR - Get Free Report) is expected to announce its Q3 2026 results after the market closes on Monday, November 9th. Analysts expect the company to announce earnings of ($0.08) per share and revenue of $5.84 million for the quarter. Investors can find conference call details on the company's upcoming Q3 2026 earnings summary page for the latest details on the call scheduled for Monday, November 9, 2026 at 4:30 PM ET.

Hyperfine (NASDAQ:HYPR - Get Free Report) last released its quarterly earnings results on Thursday, August 6th. The company reported ($0.09) EPS for the quarter, meeting the consensus estimate of ($0.09). The business had revenue of $3.90 million for the quarter, compared to the consensus estimate of $4.13 million. Hyperfine had a negative net margin of 210.75% and a negative return on equity of 97.88%.

Hyperfine Stock Performance

NASDAQ:HYPR opened at $0.73 on Monday. The company has a debt-to-equity ratio of 0.36, a quick ratio of 5.45 and a current ratio of 6.15. The company has a 50 day simple moving average of $0.81 and a two-hundred day simple moving average of $1.12. Hyperfine has a fifty-two week low of $0.70 and a fifty-two week high of $1.94. The company has a market capitalization of $77.63 million, a PE ratio of -1.94 and a beta of 1.50.

Wall Street Analysts Forecast Growth

A number of research analysts recently weighed in on HYPR shares. Lucid Cap Mkts started coverage on shares of Hyperfine in a research note on Tuesday, October 27th. They issued a "strong-buy" rating for the company. BTIG Research reiterated a "buy" rating and issued a $2.00 price objective on shares of Hyperfine in a report on Tuesday, September 22nd. B. Riley Financial reaffirmed a "buy" rating and set a $1.60 price target (down from $2.00) on shares of Hyperfine in a research report on Monday, August 10th. Loop Capital set a $2.00 price objective on shares of Hyperfine in a research note on Tuesday, October 27th. Finally, Wall Street Zen lowered Hyperfine from a "hold" rating to a "sell" rating in a research report on Saturday. One equities research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, one has given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of $2.02.

Hyperfine Company Profile

Hyperfine, Inc NASDAQ: HYPR is a medical technology company focused on making magnetic resonance imaging more accessible and convenient. The company develops portable, low-field MRI technology designed to bring brain imaging directly to patients in locations such as intensive care units, emergency departments, operating rooms and other point-of-care settings.

Hyperfine's primary product is the Swoop Portable MR Imaging System, a compact MRI platform that can be moved to a patient's bedside.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.